Note: Prices are based on MedChemExpress data and are subject to change.
(also known as Mitoglitazone) is an investigational drug originally developed to treat Type 2 diabetes. It is currently being explored for its potential to treat neurodegenerative diseases like Parkinson’s and Alzheimer’s. msdc 0160 buy
In clinical trials, MSDC-0160 has been reported as generally well-tolerated. Note: Prices are based on MedChemExpress data and
: Shown to reduce neuroinflammation and protect dopamine-producing neurons in animal models. msdc 0160 buy
As an investigational compound, MSDC-0160 is primarily sold for . It is typically found through chemical suppliers rather than standard pharmacies.